Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
This review covers pharmacologic alternatives for treating obesity, with emphasis on the benefits associated with the novel use of glucagon-like peptide-1 (GLP-1) agonists that act on satiety receptors
FM 2.0 Functional Alternatives & Natural GLP-1 Support It integrates Functional Medicine 2.0 (FM 2.0) principles precision, resilience, and system integration while preserving clarity, warmth, and evidence-based credibility
These drugs span a variety of medical conditions, including diabetes, immunology, neuroscience and oncology
Personalized care makes the difference
Tirzepatide, a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound), may indirectly affect menstrual cycles in some women
CoolMax is the largest applicator and is used for volume reduction, known as the debulking treatment
US$ 25.24
US$ 24.41
US$ 25.67
US$ 24.75
US$ 22.39
US$ 24.16
US$ 24.71
US$ 28.81
US$ 26.05
US$ 21.10
